心通醫療－Ｂ
No. 1661 Zhangdong Road
Zhangjiang Hi-Tech Park Pudong New District
Shanghai 201203
China
86 21 3895 4600
https://www.cardioflowmedtech.com
版塊: Healthcare
行業: Medical Devices
全職員工: 579
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Jeffrey R Lindstrom | Pres, GM & Exec. Director | 無 | 無 | 1966 |
| Ms. Luying Yan | VP & Exec. Director | 無 | 無 | 1982 |
| Mr. Liang Zhao | Exec. Director & First VP of Total Solutions | 無 | 無 | 1979 |
| Ms. Xiangmei Li | Joint Company Sec. | 無 | 無 | 無 |
| Ms. Lok Yee Chan A.C.I.S., A.C.S. | Joint Company Sec. | 無 | 無 | 1990 |
截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。
描述
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
公司管治
截至 無 止，心通醫療－Ｂ 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
